Insider Trading: Albany Molecular Research Inc (AMRI.O)

AMRI.O on Nasdaq

19.08USD
24 Apr 2015
Change (% chg)

$0.04 (+0.21%)
Prev Close
$19.04
Open
$19.10
Day's High
$19.37
Day's Low
$18.94
Volume
314,510
Avg. Vol
427,051
52-wk High
$23.95
52-wk Low
$13.73

Search Stocks
All Insider Trades
Trading Date Name Title Type Shares Traded Price
9 Apr 2015

D Ambra Constance M

Beneficial Owner of More than 10% Class Sell 20,000 $18.50
9 Apr 2015

D Ambra Thomas E

Chairman of the Board Sell 20,000 $18.50
6 Apr 2015

Marth William S

Chief Executive Officer Buy 10,000 $2.59
6 Apr 2015

Marth William S

Chief Executive Officer Buy 12,367 $5.99
31 Mar 2015

Cable Stuart M

Beneficial Owner of More than 10% Class Sell 30,000 $17.21
16 Mar 2015

Hagen Steven R

Officer Sell 3,500 $18.53
16 Mar 2015

Hagen Steven R

Officer Buy 3,500 $8.90
12 Mar 2015

Hagen Steven R

Officer Sell 441 $18.79
11 Mar 2015

O Connor Kevin

Director Buy 5,000 $11.85
11 Mar 2015

Roth Arthur J

Director Buy 5,000 $11.85
11 Mar 2015

Roth Arthur J

Director Sell 5,000 $18.26
11 Mar 2015

O Connor Kevin

Director Sell 5,000 $18.22
10 Mar 2015

Hagen Steven R

Officer Sell 721 $18.30
9 Mar 2015

D Ambra Constance M

Beneficial Owner of More than 10% Class Sell 20,000 $17.65
9 Mar 2015

D Ambra Thomas E

Chairman of the Board Sell 20,000 $17.65
9 Mar 2015

Svokos George

Officer Buy 10,000 $17.72
7 Mar 2015

Hagen Steven R

Officer Sell 259 $0.00
4 Mar 2015

Marth William S

Chief Executive Officer Buy 20,000 $17.70
1 Mar 2015

Jordan Veronica G H

Director Buy 2,639 $17.05
1 Mar 2015

Henderson Lori M

General Counsel Buy 10,588 $17.05
1 Mar 2015

D Ambra Thomas E

Chairman of the Board Buy 2,639 $17.05
1 Mar 2015

Roth Arthur J

Director Buy 2,639 $17.05
1 Mar 2015

Leung Gabriel

Director Buy 2,639 $17.05
1 Mar 2015

Cable Stuart M

Beneficial Owner of More than 10% Class Sell 30,000 $16.39
1 Mar 2015

Marth William S

Chief Executive Officer Buy 58,651 $17.05

Institutional Holders

% Shares Owned: 96.68%
# of Holders: 176
Total Shares Held: 31,657,141
3 Mo. Net Change: 540,668
# New Positions: 2
# Closed Positions: 1
# Increased Positions: 7
# Reduced Positions: 5
# Net Buyers: 2

Officers & Directors

Name Age Since Current Position

Thomas D' Ambra

58 2013 Non-Executive Chairman of the Board

William Marth

59 2014 President, Chief Executive Officer, Director

Felicia Ladin

43 2015 Chief Financial Officer, Senior Vice President, Treasurer

George Svokos

56 2014 Senior Vice President - Sales, General Manager - API

Christopher Conway

2015 Senior Vice President - Global Sales and Marketing

Milton Boyer

2015 Senior Vice President - Drug Product Manufacturing

Steven Hagen

53 2012 Senior Vice President - Manufacturing and Pharmaceuticals

Michael Luther

58 2013 Senior Vice President - Discovery Services

Jimmy Wang

2015 Chief Information Officer

Lori Henderson

52 2011 Vice President, General Counsel, Secretary

Una Ryan

72 2010 Lead Independent Director

Veronica Jordan

63 2006 Independent Director

Gabriel Leung

52 2010 Independent Director

Kevin O' Connor

59 2000 Independent Director

Arthur Roth

2003 Independent Director
Search Stocks